Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

AMLXAMLX
8 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in AMYLYX PHARMACEUTICALS INC

Yes. JPMorgan Chase holds 1,863,650 shares of AMLX (Amylyx Pharmaceuticals), worth $34.9M, as of its Q2 2026 13F filing. It increased the position from 159,663 shares in Q1 2026. JPMorgan Chase has held AMLX in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$34.9M

Current Shares

1.9M

Total Value Change

+$34.5M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.9M
+1067.2%
$34.9M0.0%$17.96
47
2026-Q1
Increased
159,663
+139.9%
$2M0.0%$14.11
42
2025-Q4
Increased
66,547
+85.7%
$803,8880.0%$12.00
39
2025-Q3
Decreased
35,844
-59.3%
$487,1190.0%$14.90
0
2025-Q2
Increased
87,989
+62.7%
$564,0090.0%$6.33
24
2025-Q1
Decreased
54,069
-2.8%
$191,4040.0%$3.66
0
2024-Q4
Decreased
55,606
-60.4%
$210,1910.0%$3.78
0
2024-Q3
First report
140,559
-
$455,4110.0%$3.24
0

Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used